betahistine dihydrochloride accord 8 mg tabletta
accord healthcare ltd. - betahistine dihidroklorid -
betahistine dihydrochloride accord 16 mg tabletta
accord healthcare ltd. - betahistine dihidroklorid -
betahistine dihydrochloride stada 8 mg tabletta
stada arzneimittel ag - betahistine dihidroklorid -
betahistine dihydrochloride stada 16 mg tabletta
stada arzneimittel ag - betahistine dihidroklorid -
betahistine dihydrochloride stada 24 mg tabletta
stada arzneimittel ag - betahistine dihidroklorid -
inrebic
bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - daganatellenes szerek - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.
tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - karcinóma, nem kissejtes tüdő - daganatellenes szerek - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.
cetirizine chefaro 10 mg filmtabletta
chefaro ireland dac - cetirizin-dihidroklorid -
orladeyo
biocryst ireland limited - berotralstat dihydrochloride - angioödéma, örökletes - other hematological agents - orladeyo is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in adult and adolescent patients aged 12 years and older.
sapropterin dipharma
dipharma arzneimittel gmbh - szapropterin dihidroklorid - phenylketonurias - egyéb táplálkozási traktus pedig anyagcsere termékek, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.